Gabriele Multhoff, PhD

Gabriele Multhoff currently holds a C3 Professorship in Experimental Radiation Oncology/Radiation Biology at the Department of Radiation Oncology and Radiation Therapy at the Klinikum rechts der Isar, Technical University of Munich (TUM). She is also the Founder and CSO of Multimmune GmbH and is the named inventor on multiple granted patents relating to theranostics based on her discovery of membrane Hsp70 expression on tumor cells.

Prof. Gabriele Multhoff’s research is the development of innovative immunotherapies based on targeting membrane Hsp70 on cancers. Her research led to a randomized, multicenter clinical phase II study for patients with Advanced Stage IIIb non-small cell lung carcinoma (NSCLC) after radiochemotherapy funded by the German Federal Ministry of Education and Research (BMBF) which confirmed the therapeutic potential of such targeted therapeutics.

She also invented a novel ELISA cancer monitoring test (US patent granted) which quantifies levels of exosomal, tumor-derived Hsp70 in the blood of patients.